London, 29 May 2015: Technavio, the independent tech-focused global research firm, has published a report on the stem cell banking market in India 2015-2019, which is projected to grow at an exponential rate at a CAGR of 37.85% during the forecast period of 2015-2019.
“Investments in the stem cell banks in India are primarily focused on facility building, day-to-day operations, and technology development,” says Faisal Ghaus, Vice President of Technavio.
“Many international companies, such as Cryo-Save, Cryobanks International, and Cordlife have set up stem cell banking facilities in major cities in India.”
Key Market Drivers
- Growing potential for umbilical cord cell banks
- EMI schemes by private players
- Government support for R&D
- Favorable regulatory scenario
Exciting read: India: The New Hub For Stem Cell Banking
Key Market Trends
- Introduction of new marketing concepts
- Increased investments
- Introduction of new banking services
- Increase in partnerships
Key Market Vendors
- CordLife Sciences India Pvt. Ltd.
- Cryobanks International India
- LifeCell International Pvt. Ltd.
- Reliance Life Sciences
- Stempeutics Research Pvt. Ltd.
- Tran-Scell Biologics Pvt. Ltd.
To define the market circumstances in the next 3-4 years, Technavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
